Inventor · disambiguated record
Dan H. Barouch
Also filed as: BAROUCH DAN · BAROUCH DAN H
38 granted patents·11 pending applications·166 citations·filing 2005–2025
97Inventor score
Files withBETH ISRAEL DEACONESS MEDICAL CT INC30JANSSEN VACCINES & PREVENTION BV7JANSSEN PHARMACEUTICALS INC4BAROUCH DAN H2TRIAD NAT SECURITY LLC2
Top patents by PatentIndex Score
49 records- 0194US7741099B2Adenoviral vectors and uses thereofBETH ISRAEL HOSPITAL·Filed 2005·Granted Jun 22, 2010·26 cites·12 claims
- 0293US11498944B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Nov 15, 2022·10 cites·28 claims
- 0393US10781427B2Recombinant adenoviruses and use thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Granted Sep 22, 2020·15 cites·29 claims
- 0493US9750801B2Replicating recombinant adenovirus vectors, compositions, and methods of use thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2015·Granted Sep 5, 2017·16 cites·20 claims
- 0593US9017691B2Antiviral vaccines with improved cellular immunogenicityBAROUCH DAN H·Filed 2009·Granted Apr 28, 2015·50 cites·23 claims
- 0691US11384122B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Jul 12, 2022·2 cites·30 claims
- 0788US9932370B2Stabilized mosaic human immunodeficiency virus type 1 (HIV-1) GP140 envelope (ENV) trimersBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2014·Granted Apr 3, 2018·10 cites·28 claims
- 0886US9670253B2Antiviral vaccines with improved cellular immunogenicityBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2015·Granted Jun 6, 2017·4 cites·20 claims
- 0985US10525123B2Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatmentJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jan 7, 2020·3 cites·20 claims
- 1084US10376583B2Human immunodeficiency virus therapies utilizing N332-glycan-dependent antibodies and a reservoir activatorBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2014·Granted Aug 13, 2019·4 cites·73 claims
- 1184US10307477B2Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatmentJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Jun 4, 2019·3 cites·20 claims
- 1284US10137191B2Methods and compositions for inducing protective immunity against human immunodeficiency virus infectionBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2015·Granted Nov 27, 2018·5 cites·14 claims
- 1383US9683268B2Viruses associated with immunodeficiency and enteropathy and methods using sameBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2013·Granted Jun 20, 2017·9 cites·7 claims
- 1481US11207400B2Compositions and methods for inducing protective immunity against human immunodeficiency virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Dec 28, 2021·1 cites·20 claims
- 1580US10106781B2Recombinant adenoviruses and use thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2013·Granted Oct 23, 2018·5 cites·44 claims
- 1679US12364750B1Conserved region T cell vaccines for coronavirus and methods of useTRIAD NAT SECURITY LLC·Filed 2024·Granted Jul 22, 2025·0 cites·20 claims
- 1776US10772952B2Antiviral vaccines with improved cellular immunogenicityBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Sep 15, 2020·0 cites·41 claims
- 1875US11331386B2Antiviral vaccines with improved cellular immunogenicityBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2020·Granted May 17, 2022·0 cites·27 claims
- 1975US10653770B2Biochemically stabilized HIV-1 Env trimer vaccineBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted May 19, 2020·0 cites·19 claims
- 2074US12312382B2Recombinant adenoviruses and uses thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 2174US10471137B2Methods for inducing protective immunity against human immunodeficiency virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Nov 12, 2019·1 cites·27 claims
- 2273US2022096622A1Compositions and Methods for Inducing Protective Immunity Against Human Immunodeficiency Virus InfectionJANSSEN VACCINES & PREVENTION BV·Filed 2021·Application pending·0 cites
- 2371US11229696B2Biochemically stabilized HIV-1 Env trimer vaccineBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2020·Granted Jan 25, 2022·0 cites·19 claims
- 2471US2021317169A1Stabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using sameBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2021·Application pending·0 cites
- 2570US11230572B2Signature-based human immunodeficiency virus (HIV) envelope (Env) trimer vaccines and methods of using the sameBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Jan 25, 2022·1 cites·30 claims
- 2669US12023376B1Conserved region T cell vaccines for coronavirus and methods of useTRIAD NAT SECURITY LLC·Filed 2021·Granted Jul 2, 2024·0 cites·15 claims
- 2768US10463729B2Biochemically stabilized HIV-1 env trimer vaccineBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Nov 5, 2019·0 cites·20 claims
- 2867US11059863B2Stabilized human immunodeficiency virus (HIV) envelope (ENV) trimer vaccines and methods of using sameBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Granted Jul 13, 2021·0 cites·21 claims
- 2965US10611801B2Compositions and methods for preventing and treating Zika virus infectionBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Apr 7, 2020·1 cites·28 claims
- 3065US10307478B2Biochemically stabilized HIV-1 Env trimer vaccineBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Granted Jun 4, 2019·0 cites·24 claims
- 3164US10426831B2Antiviral vaccines with improved cellular immunogenicityBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Oct 1, 2019·0 cites·40 claims
- 3263US10160788B2Stabilized human immunodeficiency virus (HIV) envelope (ENV) trimer vaccines and methods of using sameBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Granted Dec 25, 2018·0 cites·22 claims
- 3360US9950060B2Biochemically stabilized HIV-1 Env trimer vaccineBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Apr 24, 2018·0 cites·22 claims
- 3459US11773142B2Recombinant adenoviruses and uses thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Granted Oct 3, 2023·0 cites·26 claims
- 3559US11202830B2Human immunodeficiency virus therapies utilizing N332-glycan-dependent antibodies in subjects with low viral loadsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Dec 21, 2021·0 cites·43 claims
- 3658US10864263B2Method of providing safe administration of adenoviral vectors encoding a zika virus antigenJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Dec 15, 2020·0 cites·6 claims
- 3758US2023000973A1Combinations of Vaccines and Neutralizing Antibodies for Treating Human Immunodeficiency Virus Infection in Subjects Undergoing Antiretroviral TreatmentJANSSEN VACCINES & PREVENTION BV·Filed 2022·Application pending·0 cites
- 3855US2021113682A1Method of providing safe administration of adenoviral vectors encoding a zika virus antigenJANSSEN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3952US2022401542A1Mycobacterial compositions and biomarkers for use in treatment and monitoring of therapeutic responsivenessBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2020·Application pending·0 cites
- 4051US12459989B2Antibody therapies for human immunodeficiency virus (HIV)BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Nov 4, 2025·0 cites·20 claims
- 4150US2021317192A9Hiv-1 specific immunogen compositions and methods of useMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Application pending·0 cites
- 4249US10716845B2Stabilized human immunodeficiency virus (HIV) clade C envelope (Env) trimer vaccines and methods of using sameBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2014·Granted Jul 21, 2020·0 cites·18 claims
- 4348US2010143302A1Recombinant Adenoviruses Based on Serotype 26 and 48, and Use ThereofCRUCELL HOLLAND BV·Filed 2007·Application pending·0 cites
- 4447US2019022212A1Methods for safe induction of cross-clade immunity against human immunodeficiency virus infection in humanBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Application pending·0 cites
- 4547US2025333454A1Recombinant adenoviruses and uses thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2025·Application pending·0 cites
- 4645US11845788B2Antibody therapies for human immunodeficiency virus (HIV)BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Dec 19, 2023·0 cites·13 claims
- 4742US2014348791A1Modified adenoviral vectors and methods of treatment using sameBAROUCH DAN H·Filed 2012·Application pending·0 cites
- 4839US2019083620A1Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatmentJANSSEN VACCINES & PREVENTION BV·Filed 2018·Application pending·0 cites
- 4935US11884718B2Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccinationHENRY M JACKSON FOUND ADVANCEMENT MILITARY MEDICINE INC·Filed 2019·Granted Jan 30, 2024·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →